Why is Senores Pharma. falling/rising?

As of 22-Sep, Senores Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 706.30, which reflects a decrease of 5.5 points or 0.77%. The stock has been underperforming recently, having fallen for the last two days with a total decline of 1.34%. Despite outperforming its sector by 0.31% today, the stock's performance over the past month shows a decrease of 2.40%, while it has gained 2.85% over the past week. The stock's delivery volume has also decreased significantly, indicating falling investor participation, which may contribute to the downward pressure on the price. Additionally, while the company has shown strong long-term growth with impressive increases in net sales and operating profit, its high valuation metrics, such as a Price to Book Value of 4.1 and a low Return on Equity of 7.4, may deter investors.
In the broader market context, the stock's recent performance contrasts with the benchmark Sensex, which has increased by 0.46% over the past week and 1.05% over the past month. This suggests that while Senores Pharmaceuticals has had a strong year-to-date return of 24.15%, its recent struggles may be compounded by a general market environment that is performing better. Furthermore, the decline in institutional investor participation, with a reduction of 0.65% in their stake, indicates a lack of confidence from more sophisticated investors, which could further impact the stock's price negatively.